glp-1 during pregnancy Study finds no major early risks tied to drugs, but doctors still advise against use Discontinuing GLP-1s Before or Early

Its totally doable to enjoy your favorite quick bites while staying on track with your health goals

While newly approved pharmacotherapies such as glucagon-like peptide-1 receptor agonists (GLP-1 RAs) show efficacy, their clinical utility remains constrained by dose-dependent gastrointestinal complications, underscoring the urgent need for safer alternatives

I'm crushin' it" campaign highlights the GLP-1 supporting supplement where people are most tempted.

Experiencing fatigue on semaglutide or tirzepatide

Compared with SGLT-2 inhibitor use, GLP-1 receptor agonist use was not associated with an increased risk of pulmonary aspiration (pooled risk ratio 0.98, 95% CI 0.73 to 1.31), although it was associated with a higher risk for discontinuation of endoscopy (1.99, 1.56 to 2.53)

Learn about safety considerations, side effects, monitoring requirements, and practical guidance for taking these medications together for diabetes and mental health.